Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Lawsuit Claims Cartiva Recall Should Have Been Issued For Big Toe Synthetic Cartilage Implant (SCI) Manufacturer failed to issue a Cartiva SCI recall even after receiving nearly 150 reports of implant failures and device loosening, according to the lawsuit. July 10, 2024 Irvin Jackson Add Your Comments A product liability lawsuit filed by a West Virginia man argues that there should have been a Cartiva recall issued after the manufacturer began receiving reports of failures involving the synthetic cartilage implant (SCI), which has been used in recent years to treat individuals big toe arthritis. The Cartiva SCI is a molded cylindrical implant made of polyvinyl alcohol-based hydrogel (PVA), which has been promoted by the manufacturer as a revolutionary toe implant. However, within a few years after it was introduced, concerns emerged about alarming Cartiva synthetic cartilage implant failure rates, which have caused patients to experience widespread complications, including reports of severe toe pain, loosening, fracture and other problems, often resulting in the need for a surgery to fuse the big toe, resulting in a loss of mobility. As a result, the manufacturers now face a growing number of similar Cartiva SCI lawsuits, each raising allegations that the device was defectively designed and contained known risks that were not disclosed to patients and doctors. Cartiva Lawsuit Did you or a loved one receive a Cartiva Toe Implant? Lawyers are reviewing Cartiva lawsuits for individuals who experienced complications after receiving the toe implant. Settlement benefits may be available. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Cartiva Lawsuit Did you or a loved one receive a Cartiva Toe Implant? Lawyers are reviewing Cartiva lawsuits for individuals who experienced complications after receiving the toe implant. Settlement benefits may be available. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In a complaint (PDF) filed late last month in the U.S. District Court for the Southern District of West Virginia, Bryan Hughes indicates that the manufacturers ignored signs of problems with the big toe synthetic cartilage implant and failed to issue a Cartiva recall, which may have allowed many individuals to avoid devastating foot injuries. Hughes indicates that he received a Cartiva synthetic cartilage implant in September 2019, for the treatment of hallux rigidis and capsulitis. However, the lawsuit indicates that not only did the Cartiva SCI not alleviate his pain or restore motion, but ot also led to permanent restrictions in the use of Hughe’s big toe. This led to him being forced to adapt using other joints, which led to wear and tear on his foot and leg. As a result of the Cartiva complications, Hughes had to undergo removal of the big toe implant in February 2023. However, he continues to experience severe and painful injuries, which the lawsuit indicates are permanent. The lawsuit names Cartiva Inc., Wright Medical Group, N.V. and Stryker B.V. as defendants, indicating that the manufacturers were aware of the serious risk of problems from Cartiva long before he had the synthetic cartilage implant placed in his big toe. Hughes notes that at least 144 adverse event reports had been submitted by that time, involving Cartiva implants loosening or failing. According to the complaint, this loosening is likely due to shrinkage of the implant, which is what caused Hughes Cartiva toe implant to fail. “Defendants had the ability of a voluntary recall at their disposal to protect the public from the known shrinkage, migration and bone loss issues associated with SCIs,” the lawsuit states. “The Defendants continued to market and sell a defective device that they knew should have been voluntarily recalled, in violation of federal regulations including making an adulterated device that proximately and directly caused Plaintiff’s injuries and damages.” The lawsuit presents claims of strict products liability, negligent design, manufacture and distribution, misbranded and adulterated device, common law product liability and negligence, and breach of warranty. Hughes seeks both compensatory and punitive damages. Cartiva Implant Lawsuits Being Pursued Nationwide Although the manufacturer originally suggested Cartiva synthetic cartilage implant failure rates were low, Hughes’ and other plaintiffs now pursuing product liability lawsuits point to a study published in November 2020, which found that as many as 64% of individuals who received a Cartiva SCI for hallux rigidus experienced failure within four weeks of surgery, and the failure rate increased to 79% after 19 months. Some reports also suggest that Cartiva SCI failures have left individuals in a much worse position, due to the amount of bone removed during the toe implant surgery. In this scenario, patients have been left with significantly shorted big toes, which can lead to additional foot injuries from the offloading effect. Such poor patient outcomes will likely result in many more implant recipients seeking settlements or compensation from the manufacturer through the filing of a Cartiva lawsuit, alleging that the manufacturer did not uphold their duty to adequately investigate and ensure that the devices were safe. The company also faces claims that it failed to promptly issue a Cartiva recall, or adequately warn patients about the increased risk of implant failure. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Big Toe, Cartiva, Stryker, Surgery, Wright Medical Find Out If You Qualify for Cartiva Failure Compensation More Cartiva Lawsuit Stories Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant September 18, 2025 Cartiva Lawyers Select Settlement Mediator in Toe Implant Lawsuit September 12, 2025 Lawsuit Claims Cartiva Implant Caused Bone Loss and Nerve Damage in Big Toe August 12, 2025 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: yesterday) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023) Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 2 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025) Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 3 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025)
Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: yesterday) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 2 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 3 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025)